Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes

Abstract

AbstractAimTo investigate the relationship between continuous glucose monitoring (CGM)‐derived glucometrics and metabolic dysfunction‐associated steatotic liver disease (MASLD) in type 1 diabetes (T1D).MethodsA cross‐sectional study collecting data on anthropometrics, glucometrics and MASLD in adults with T1D using a CGM device was conducted. MASLD was assessed by abdominal ultrasound and the presence of at least one cardiometabolic criterion. Backward multivariable logistic regression models were applied to define variables independently associated with MASLD.ResultsA total of 302 consecutive participants were included (median age 49 [34‐61] years, male sex 58%, median diabetes duration 29 [17‐38] years, mean time in range [TIR] 55% ± 16%). MASLD was present in 17% of cases, and 32% had metabolic syndrome (MetS). MetS was significantly more prevalent in the MASLD group (65% vs. 25%, P < .0001). TIR (P = .038) and time below range (TBR) (P = .032) were lower and time above range (TAR) was higher (P = .006), whereas HbA1c did not reach significance (P = .068). No differences were found for the glycaemia risk index. TIR (P = .028), TAR (P = .007), TBR (P = .036), waist circumference (P < .001) and systolic blood pressure (P = .029) were independently associated with MASLD, while sex, age, aspartate aminotransferase/alanine aminotransferase ratio, gamma‐glutamyl transferase, high‐density lipoprotein cholesterol and triglycerides were not.ConclusionsTIR, TAR, TBR, waist circumference and systolic blood pressure were independently associated with MASLD.